Quantib

Quantib, originally a spin-off from Erasmus MC, developed AI-powered radiology software for the automatic analysis of medical imaging data such as MRI and CT scans. The company’s core product utilizes advanced machine learning techniques to enhance diagnostic accuracy and shorten the diagnosis process by detecting subtle tissue changes earlier. Quantib’s solutions, including products for prostate cancer detection (Quantib Prostate), neurodegenerative disease assessment (Quantib ND), and brain atrophy quantification, aim to provide objective and efficient clinical decision-making. Quantib was acquired by RadNet in 2022 and became part of DeepHealth in 2023.